Abstract
Chronic inflammatory skin disorders are known to affect sleep quality; however, the relationship between hidradenitis suppurativa (HS) and sleep is not well understood. We performed a systematic review of HS and sleep disorders and sleep quality in HS patients. We identified seven studies comprising 343,870 subjects. We found that HS patients have a higher likelihood of having a sleep disorder such as obstructive sleep apnea, as well as other non-sleep apnea. Several studies showed that patients reported worse sleep quality due to symptoms of HS such as pruritus and pain. HS patients may be at risk for additional cardiovascular comorbidities and poorer quality of life secondary to these sleep disorders and poor sleep quality. Further high-quality research evaluating these associations is warranted.
Data availability
The authors confirm that the data supporting the findings of this study are available within the article and/or its supplementary materials.
References
Jensen P, Zachariae C, Skov L, Zachariae R (2018) Sleep disturbance in psoriasis: a case-controlled study. Br J Dermatol 179(6):1376–1384. https://doi.org/10.1111/bjd.16702
Tietjens JR et al (2019) Obstructive sleep apnea in cardiovascular disease: a review of the literature and proposed multidisciplinary clinical management strategy. J Am Heart Assoc. https://doi.org/10.1161/JAHA.118.010440?cookieSet=1
Critical Appraisal Skills Programme (2018). CASP (Cohort Study). https://casp-uk.net/casp-tools-checklists/. Accessed 11 May 2022
Cohen JM, Kridin K, Perez-Chada LM, Merola JF, Cohen AD (2021) Hidradenitis suppurativa and sleep disorders: a population-based study. J Eur Acad Dermatol Venereol 35(8):e520–e522. https://doi.org/10.1111/jdv.17293
Kaaz K, Szepietowski JC, Matusiak Ł (2018) Influence of Itch and Pain on Sleep Quality in Patients with Hidradenitis Suppurativa. Acta Derm Venereol 98(8):757–761. https://doi.org/10.2340/00015555-2967
Kelly A, Meurling J, Kirthi Jeyarajah S et al (2021) Obstructive sleep apnoea in psoriasis and hidradenitis suppurativa. Br J Dermatol 184(6):1183–1185. https://doi.org/10.1111/bjd.19802
Kimball AB, Sundaram M, Gauthier G et al (2018) The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis. Dermatol and Ther 8(4). https://doi.org/10.1007/s13555-018-0264-z
Matusiak Ł, Szczęch J, Kaaz K, Lelonek E, Szepietowski JC (2018) Clinical Characteristics of Pruritus and Pain in Patients with Hidradenitis Suppurativa. Acta Derm Venereol 98(2):191–194. https://doi.org/10.2340/00015555-2815
Vossen ARJV, Schoenmakers A, van Straalen KR, Prens EP, van der Zee HH (2017) Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study. Am J Clin Dermatol 18(5):687–695. https://doi.org/10.1007/s40257-017-0280-2
Wertenteil S, Strunk A, Garg A (2018) Incidence of obstructive sleep apnoea in patients with hidradenitis suppurativa: a retrospective population-based cohort analysis. Br J Dermatol 179(6):1398–1399. https://doi.org/10.1111/bjd.16931
Cao Y, Song Y, Ning P et al (2020) Association between tumor necrosis factor alpha and obstructive sleep apnea in adults: a meta-analysis update. BMC Pulm Med 20(1):215. https://doi.org/10.1186/s12890-020-01253-0
Goldburg SR, Strober BE, Payette MJ (2020) Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 82(5):1045–1058. https://doi.org/10.1016/j.jaad.2019.08.090
Funding
None.
Author information
Authors and Affiliations
Contributions
SY, AI, and KE conceptualized, wrote, and edited the main manuscript text. SY and AI created figure 1 and table 1. MC, EB, and MH edited the main manuscript. PT conducted the review. HN, TB, and WL conceptualized and edited the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Haley Naik has received grant support from Abbvie; consulting fees from 23andme, Abbvie, Aristea Therapeutics, Nimbus Therapeutics, Medscape, and DAVA Oncology; advisory board fees from Boehringer Ingelheim; and investigator fees from Pfizer. She is also an Associate Editor for JAMA Dermatology and an unpaid board member of the US Hidradenitis Suppurativa Foundation. Tina Bhutani is a principal investigator for trials sponsored by Abbvie, Castle, CorEvitas, Dermavant, Galderma, Mindera, and Pfizer. She has received research grant funding from Novartis and Regeneron. She has been an advisor for Abbvie, Arcutis, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Leo, Lilly, Novartis, Pfizer, Sun, and UCB. Wilson Liao has received research grant funding from Abbvie, Amgen, Janssen, Leo, Novartis, Pfizer, Regeneron, and TRex Bio. The remaining authors have nothing to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yeroushalmi, S., Ildardashty, A., Elhage, K.G. et al. Hidradenitis suppurativa and sleep: a systematic review. Arch Dermatol Res 315, 1409–1415 (2023). https://doi.org/10.1007/s00403-022-02460-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-022-02460-x